Verteporfin?a benzoporphyrin derivative, is a medication used as a photosensitizer for photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with conditions such as the wet form of macular degeneration.
This report aims to provide a comprehensive presentation of the global market for Liposomal Verteporfin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomal Verteporfin. This report contains market size and forecasts of Liposomal Verteporfin in global, including the following market information:
Global Liposomal Verteporfin Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Liposomal Verteporfin Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Liposomal Verteporfin companies in 2022 (%)
The global Liposomal Verteporfin market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Brands Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Liposomal Verteporfin include Novartis and Bausch & Lomb etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Liposomal Verteporfin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposomal Verteporfin Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Liposomal Verteporfin Market Segment Percentages, by Type, 2022 (%)
Brands
Generic
Global Liposomal Verteporfin Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Liposomal Verteporfin Market Segment Percentages, by Application, 2022 (%)
Hospital
Drugs Store
Global Liposomal Verteporfin Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Liposomal Verteporfin Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liposomal Verteporfin revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Liposomal Verteporfin revenues share in global market, 2022 (%)
Key companies Liposomal Verteporfin sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Liposomal Verteporfin sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Bausch & Lomb
Outline of Major Chapters:
Chapter 1: Introduces the definition of Liposomal Verteporfin, market overview.
Chapter 2: Global Liposomal Verteporfin market size in revenue and volume.
Chapter 3: Detailed analysis of Liposomal Verteporfin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liposomal Verteporfin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Liposomal Verteporfin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Liposomal Verteporfin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liposomal Verteporfin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liposomal Verteporfin Overall Market Size
2.1 Global Liposomal Verteporfin Market Size: 2022 VS 2030
2.2 Global Liposomal Verteporfin Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Liposomal Verteporfin Sales: 2018-2030
3 Company Landscape
3.1 Top Liposomal Verteporfin Players in Global Market
3.2 Top Global Liposomal Verteporfin Companies Ranked by Revenue
3.3 Global Liposomal Verteporfin Revenue by Companies
3.4 Global Liposomal Verteporfin Sales by Companies
3.5 Global Liposomal Verteporfin Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Liposomal Verteporfin Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Liposomal Verteporfin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Liposomal Verteporfin Players in Global Market
3.8.1 List of Global Tier 1 Liposomal Verteporfin Companies
3.8.2 List of Global Tier 2 and Tier 3 Liposomal Verteporfin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Liposomal Verteporfin Market Size Markets, 2022 & 2030
4.1.2 Brands
4.1.3 Generic
4.2 By Type - Global Liposomal Verteporfin Revenue & Forecasts
4.2.1 By Type - Global Liposomal Verteporfin Revenue, 2018-2023
4.2.2 By Type - Global Liposomal Verteporfin Revenue, 2024-2030
4.2.3 By Type - Global Liposomal Verteporfin Revenue Market Share, 2018-2030
4.3 By Type - Global Liposomal Verteporfin Sales & Forecasts
4.3.1 By Type - Global Liposomal Verteporfin Sales, 2018-2023
4.3.2 By Type - Global Liposomal Verteporfin Sales, 2024-2030
4.3.3 By Type - Global Liposomal Verteporfin Sales Market Share, 2018-2030
4.4 By Type - Global Liposomal Verteporfin Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liposomal Verteporfin Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Drugs Store
5.2 By Application - Global Liposomal Verteporfin Revenue & Forecasts
5.2.1 By Application - Global Liposomal Verteporfin Revenue, 2018-2023
5.2.2 By Application - Global Liposomal Verteporfin Revenue, 2024-2030
5.2.3 By Application - Global Liposomal Verteporfin Revenue Market Share, 2018-2030
5.3 By Application - Global Liposomal Verteporfin Sales & Forecasts
5.3.1 By Application - Global Liposomal Verteporfin Sales, 2018-2023
5.3.2 By Application - Global Liposomal Verteporfin Sales, 2024-2030
5.3.3 By Application - Global Liposomal Verteporfin Sales Market Share, 2018-2030
5.4 By Application - Global Liposomal Verteporfin Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Liposomal Verteporfin Market Size, 2022 & 2030
6.2 By Region - Global Liposomal Verteporfin Revenue & Forecasts
6.2.1 By Region - Global Liposomal Verteporfin Revenue, 2018-2023
6.2.2 By Region - Global Liposomal Verteporfin Revenue, 2024-2030
6.2.3 By Region - Global Liposomal Verteporfin Revenue Market Share, 2018-2030
6.3 By Region - Global Liposomal Verteporfin Sales & Forecasts
6.3.1 By Region - Global Liposomal Verteporfin Sales, 2018-2023
6.3.2 By Region - Global Liposomal Verteporfin Sales, 2024-2030
6.3.3 By Region - Global Liposomal Verteporfin Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Liposomal Verteporfin Revenue, 2018-2030
6.4.2 By Country - North America Liposomal Verteporfin Sales, 2018-2030
6.4.3 US Liposomal Verteporfin Market Size, 2018-2030
6.4.4 Canada Liposomal Verteporfin Market Size, 2018-2030
6.4.5 Mexico Liposomal Verteporfin Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Liposomal Verteporfin Revenue, 2018-2030
6.5.2 By Country - Europe Liposomal Verteporfin Sales, 2018-2030
6.5.3 Germany Liposomal Verteporfin Market Size, 2018-2030
6.5.4 France Liposomal Verteporfin Market Size, 2018-2030
6.5.5 U.K. Liposomal Verteporfin Market Size, 2018-2030
6.5.6 Italy Liposomal Verteporfin Market Size, 2018-2030
6.5.7 Russia Liposomal Verteporfin Market Size, 2018-2030
6.5.8 Nordic Countries Liposomal Verteporfin Market Size, 2018-2030
6.5.9 Benelux Liposomal Verteporfin Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Liposomal Verteporfin Revenue, 2018-2030
6.6.2 By Region - Asia Liposomal Verteporfin Sales, 2018-2030
6.6.3 China Liposomal Verteporfin Market Size, 2018-2030
6.6.4 Japan Liposomal Verteporfin Market Size, 2018-2030
6.6.5 South Korea Liposomal Verteporfin Market Size, 2018-2030
6.6.6 Southeast Asia Liposomal Verteporfin Market Size, 2018-2030
6.6.7 India Liposomal Verteporfin Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Liposomal Verteporfin Revenue, 2018-2030
6.7.2 By Country - South America Liposomal Verteporfin Sales, 2018-2030
6.7.3 Brazil Liposomal Verteporfin Market Size, 2018-2030
6.7.4 Argentina Liposomal Verteporfin Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Liposomal Verteporfin Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Liposomal Verteporfin Sales, 2018-2030
6.8.3 Turkey Liposomal Verteporfin Market Size, 2018-2030
6.8.4 Israel Liposomal Verteporfin Market Size, 2018-2030
6.8.5 Saudi Arabia Liposomal Verteporfin Market Size, 2018-2030
6.8.6 UAE Liposomal Verteporfin Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Liposomal Verteporfin Major Product Offerings
7.1.4 Novartis Liposomal Verteporfin Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Bausch & Lomb
7.2.1 Bausch & Lomb Company Summary
7.2.2 Bausch & Lomb Business Overview
7.2.3 Bausch & Lomb Liposomal Verteporfin Major Product Offerings
7.2.4 Bausch & Lomb Liposomal Verteporfin Sales and Revenue in Global (2018-2023)
7.2.5 Bausch & Lomb Key News & Latest Developments
8 Global Liposomal Verteporfin Production Capacity, Analysis
8.1 Global Liposomal Verteporfin Production Capacity, 2018-2030
8.2 Liposomal Verteporfin Production Capacity of Key Manufacturers in Global Market
8.3 Global Liposomal Verteporfin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Liposomal Verteporfin Supply Chain Analysis
10.1 Liposomal Verteporfin Industry Value Chain
10.2 Liposomal Verteporfin Upstream Market
10.3 Liposomal Verteporfin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Liposomal Verteporfin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Liposomal Verteporfin in Global Market
Table 2. Top Liposomal Verteporfin Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Liposomal Verteporfin Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Liposomal Verteporfin Revenue Share by Companies, 2018-2023
Table 5. Global Liposomal Verteporfin Sales by Companies, (K Units), 2018-2023
Table 6. Global Liposomal Verteporfin Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Liposomal Verteporfin Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Liposomal Verteporfin Product Type
Table 9. List of Global Tier 1 Liposomal Verteporfin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposomal Verteporfin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Liposomal Verteporfin Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Liposomal Verteporfin Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Liposomal Verteporfin Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Liposomal Verteporfin Sales (K Units), 2018-2023
Table 15. By Type - Global Liposomal Verteporfin Sales (K Units), 2024-2030
Table 16. By Application ? Global Liposomal Verteporfin Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Liposomal Verteporfin Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Liposomal Verteporfin Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Liposomal Verteporfin Sales (K Units), 2018-2023
Table 20. By Application - Global Liposomal Verteporfin Sales (K Units), 2024-2030
Table 21. By Region ? Global Liposomal Verteporfin Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Liposomal Verteporfin Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Liposomal Verteporfin Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Liposomal Verteporfin Sales (K Units), 2018-2023
Table 25. By Region - Global Liposomal Verteporfin Sales (K Units), 2024-2030
Table 26. By Country - North America Liposomal Verteporfin Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Liposomal Verteporfin Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Liposomal Verteporfin Sales, (K Units), 2018-2023
Table 29. By Country - North America Liposomal Verteporfin Sales, (K Units), 2024-2030
Table 30. By Country - Europe Liposomal Verteporfin Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Liposomal Verteporfin Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Liposomal Verteporfin Sales, (K Units), 2018-2023
Table 33. By Country - Europe Liposomal Verteporfin Sales, (K Units), 2024-2030
Table 34. By Region - Asia Liposomal Verteporfin Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Liposomal Verteporfin Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Liposomal Verteporfin Sales, (K Units), 2018-2023
Table 37. By Region - Asia Liposomal Verteporfin Sales, (K Units), 2024-2030
Table 38. By Country - South America Liposomal Verteporfin Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Liposomal Verteporfin Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Liposomal Verteporfin Sales, (K Units), 2018-2023
Table 41. By Country - South America Liposomal Verteporfin Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Liposomal Verteporfin Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Liposomal Verteporfin Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Liposomal Verteporfin Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Liposomal Verteporfin Sales, (K Units), 2024-2030
Table 46. Novartis Company Summary
Table 47. Novartis Liposomal Verteporfin Product Offerings
Table 48. Novartis Liposomal Verteporfin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Bausch & Lomb Company Summary
Table 51. Bausch & Lomb Liposomal Verteporfin Product Offerings
Table 52. Bausch & Lomb Liposomal Verteporfin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Bausch & Lomb Key News & Latest Developments
Table 54. Liposomal Verteporfin Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 55. Global Liposomal Verteporfin Capacity Market Share of Key Manufacturers, 2021-2023
Table 56. Global Liposomal Verteporfin Production by Region, 2018-2023 (K Units)
Table 57. Global Liposomal Verteporfin Production by Region, 2024-2030 (K Units)
Table 58. Liposomal Verteporfin Market Opportunities & Trends in Global Market
Table 59. Liposomal Verteporfin Market Drivers in Global Market
Table 60. Liposomal Verteporfin Market Restraints in Global Market
Table 61. Liposomal Verteporfin Raw Materials
Table 62. Liposomal Verteporfin Raw Materials Suppliers in Global Market
Table 63. Typical Liposomal Verteporfin Downstream
Table 64. Liposomal Verteporfin Downstream Clients in Global Market
Table 65. Liposomal Verteporfin Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Liposomal Verteporfin Segment by Type in 2022
Figure 2. Liposomal Verteporfin Segment by Application in 2022
Figure 3. Global Liposomal Verteporfin Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Liposomal Verteporfin Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Liposomal Verteporfin Revenue, 2018-2030 (US$, Mn)
Figure 7. Liposomal Verteporfin Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Liposomal Verteporfin Revenue in 2022
Figure 9. By Type - Global Liposomal Verteporfin Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Liposomal Verteporfin Revenue Market Share, 2018-2030
Figure 11. By Type - Global Liposomal Verteporfin Sales Market Share, 2018-2030
Figure 12. By Type - Global Liposomal Verteporfin Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Liposomal Verteporfin Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Liposomal Verteporfin Revenue Market Share, 2018-2030
Figure 15. By Application - Global Liposomal Verteporfin Sales Market Share, 2018-2030
Figure 16. By Application - Global Liposomal Verteporfin Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Liposomal Verteporfin Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Liposomal Verteporfin Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Liposomal Verteporfin Revenue Market Share, 2018-2030
Figure 20. By Region - Global Liposomal Verteporfin Sales Market Share, 2018-2030
Figure 21. By Country - North America Liposomal Verteporfin Revenue Market Share, 2018-2030
Figure 22. By Country - North America Liposomal Verteporfin Sales Market Share, 2018-2030
Figure 23. US Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Liposomal Verteporfin Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Liposomal Verteporfin Sales Market Share, 2018-2030
Figure 28. Germany Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 29. France Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Liposomal Verteporfin Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Liposomal Verteporfin Sales Market Share, 2018-2030
Figure 37. China Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 41. India Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Liposomal Verteporfin Revenue Market Share, 2018-2030
Figure 43. By Country - South America Liposomal Verteporfin Sales Market Share, 2018-2030
Figure 44. Brazil Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Liposomal Verteporfin Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Liposomal Verteporfin Sales Market Share, 2018-2030
Figure 48. Turkey Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Liposomal Verteporfin Revenue, (US$, Mn), 2018-2030
Figure 52. Global Liposomal Verteporfin Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Liposomal Verteporfin by Region, 2022 VS 2030
Figure 54. Liposomal Verteporfin Industry Value Chain
Figure 55. Marketing Channels
